Burden of hereditary transthyretin amyloidosis on quality of life-Reference-Cited by-同舟云学术

Burden of hereditary transthyretin amyloidosis on quality of life

Published:2019-06-13 Issue:2 Volume:60 Page:169-175
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Yarlas Aaron¹^ORCID,Gertz Morie A.²,Dasgupta Noel R.³,Obici Laura⁴,Pollock Michael⁵,Ackermann Elizabeth J.⁵,Lovley Andrew¹,Kessler Asia Sikora¹,Patel Pankaj A.⁶,White Michelle K.¹,Guthrie Spencer D.⁷

Affiliation:

1. Optum 1301 Atwood Avenue, Suite 311N, Johnston Rhode Island 02919 USA

2. Division of HematologyMayo Clinic Rochester Minnesota USA

3. Department of Cardiology, Indiana University School of Medicine Indianapolis Indiana USA

4. Amyloidosis Research and Treatment CenterFondazione IRCCS Policlinico S. Matteo Pavia Italy

5. Akcea Therapeutics Boston Massachusetts USA

6. Kantar Health Chicago Illinois USA

7. Biopharma Strategic Consulting San Francisco California USA

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.26515

Reference20 articles.

1. The Systemic Amyloidoses

2. Amyloid Neuropathies

3. Systemic Amyloidoses

4. Guideline of transthyretin-related hereditary amyloidosis for clinicians

5. Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding Energetics

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zerebrale Amyloidangiopathie;Neurologie up2date;2024-09

2. Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin‐mediated amyloidosis with polyneuropathy;European Journal of Neurology;2024-07-10

3. Early diagnosis in ATTRv amyloidosis, how early is enough? How early is possible?;Medicina Clínica;2024-06

4. Early diagnosis in ATTRv amyloidosis, how early is enough? How early is possible?;Medicina Clínica (English Edition);2024-06

5. Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy;Neurological Sciences;2024-04-16